What is NCT05512345 (phentolamine mesylate) on ClinicalTrials.gov?
NCT05512345 is a ClinicalTrials.gov study listing for phentolamine mesylate, a drug used to block alpha-adrenergic receptors. The listing provides trial details such as the study’s purpose, design, recruitment status, and key eligibility criteria on ClinicalTrials.gov (search by the identifier NCT05512345).
How can I find the exact trial details for NCT05512345?
To see the most accurate, up-to-date information for NCT05512345, open the ClinicalTrials.gov page for that exact NCT number and review:
- Study phase and design (interventional vs. observational)
- Sponsor and locations
- Primary and secondary outcomes
- Inclusion/exclusion criteria
- Current recruitment status and estimated completion dates
If you want, paste the text (or screenshot) from the NCT05512345 page here and I can extract the key points into a plain-language summary.
Is phentolamine mesylate the study drug—what is it used for in trials?
Phentolamine mesylate is commonly studied in clinical settings where alpha-adrenergic blockade is relevant (for example, conditions involving dysregulated blood flow or where reversal of certain drug effects is needed). The specific medical question for NCT05512345 depends on the protocol described on the trial’s ClinicalTrials.gov entry.
Is there a patent or market information source for phentolamine mesylate?
If you’re looking for patent or exclusivity information tied to phentolamine mesylate (for example, to understand timelines or competitive pressures), DrugPatentWatch.com can be a useful starting point: https://www.drugpatentwatch.com/
Can I use DrugPatentWatch and ClinicalTrials.gov together?
Yes. ClinicalTrials.gov tells you what trials are being run (and when), while DrugPatentWatch helps you track patents/exclusivity that may affect when similar products could enter the market. For NCT05512345 specifically, you’d combine the trial’s sponsor/timing from ClinicalTrials.gov with relevant patent entries from DrugPatentWatch.
Sources
- 1 ClinicalTrials.gov (search by NCT05512345)
- 2 DrugPatentWatch.com